RIGL · All filings · Read this filing
What changed 10-Q
Item 1. Legal Proceedings
2023-11-07 compared with 2023-08-01 · 2 added, 1 removed, 11 unchanged (21% of the section changed)
2 unchanged sentences
Some of these proceedings that we may be involved in the future, are claims that are subject to substantial uncertainties and unascertainable damages or other remedies.
+Added: Our threshold for disclosing material environmental legal proceedings involving a government authority where potential monetary sanctions are involved is $1.0 million.
In June 2022, we received a notice letter regarding an ANDA submitted to the FDA by Annora, requesting approval to market a generic version of TAVALISSE.
4 unchanged sentences
We served an answer to Annora’s invalidity and non-infringement contentions in March 2023.
−Removed: Litigation continues with preparation for Markman hearing expected later this year.
+Added: Litigation continues with preparation for a Markman hearing expected early next year.
We intend to vigorously enforce and defend our intellectual property related to TAVALISSE.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.